Limited availability of Visudyne 15 mg powder for solution for intravenous infusion: recommendations for (hospital) pharmacists and medical specialists
Due to a delay in production, the availability of Visudyne, a medicine used in ophthalmology, has been limited since 9 December 2024. This situation is expected to continue until at least the end of April 2026. The experts of the FAMHP’s Unavailability Task Force are making the following recommendations to (hospital) pharmacists and medical specialists.